Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment of the day
    • StanPlus raises 1.1...

    StanPlus raises 1.1 million dollars of seed funding from Kstart Capital, INSEAD Angels Asia

    Written by Ruby Khatun Khatun Published On 2017-10-15T10:30:03+05:30  |  Updated On 15 Oct 2017 10:30 AM IST
    StanPlus raises 1.1 million dollars of seed funding from Kstart Capital, INSEAD Angels Asia

    Hyderabad: StanPlus, the Hyderabad based medical transportation startup announced securing an investment of $1.1 million funding as Seed funding for a minority stake.


    The latest round of investment is being led by Kstart (Kalaari Capital’s Seed Fund) and co-invested by CM Diamant, a chain of medical centers and hospital in Canada and Africa, and INSEAD Angels (Asia).


    Speaking on the utilization of the funding, Mr. Prabhdeep Singh, Co-Founder & CEO says “The amount invested will be used to increase our Advance-Life Support fleet and expand across geographies, innovate with cutting-edge technologies and to cover all medical transportation categories in near future”


    StanPlus receives an average of 60+ calls per day. With a fleet of 300+ Ambulances, 60+ ambulance operators on board, 15 hospitals accounting for 2000+ beds that exclusively use StanPlus’ highly dependable ambulance network, the company gives customers a single number access to every hospital’s ambulance.


    Adding to this, Mr. Antoine Poirson, Co-Founder & COO says, “Our aim is to empower people during difficult situations. We see a huge gap in the ambulance transportation service from home to hospital and hospital to home, especially in the non-emergency sector. In fact, our successful operations have only strengthened our relationship with private and general hospitals allowing them to focus on providing the best care to patients, outsourcing logistics and transportation hassle to us. With this additional investment, we would like to continue our remarkable growth of the last 1 year and supplement our vision and mission.”


    Speaking on the technology front, “the additional investment would be utilized to augment our technology. There’s a lot that we are doing that has never been done before anywhere in the world ”, adds Jose Leon, Co-Founder & Technical Advisor.


    “StanPlus’s approach to medical transportation is enterprising,” says Muthiah Venkateswaran, Partner at Kstart, a seed fund initiative of Kalaari Capital, one of India’s leading Venture Capital firms. “We are confident in their ability to achieve scale and successfully address the problem of lack of reliable medical transportation services across all areas of healthcare.”



    Antoine PoirsonFund raisefund raisingfundingHealthcare IThealthcare it newsINSEAD Angels AsiaJose LeonKalaari CapitalKstart CapitalMuthiah VenkateswaranPrabhdeep SinghRaisesseed fundingStanPlus
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok